Department: Pharmaceutical Sciences and Dermatology
University: University of California San Diego
Country: United States
Farid Menaa (B.Sc. Eng., B.Sc. Bio., M.Sc. Genetics, Master Gerontology/Geriatry, Ph.D. Radiation Oncology and Gerontology, EMBA Entrepreneurship and MD candidate), is an inter- and multi-disciplinary professional. He is a Professor, principal investigator, Director, consultant editor, reviewer, event organizer, and entrepreneur. He earned his degrees with highest distinctions from prestigious French universities and institutions. He followed a post-doctoral in oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, he pursued his career in dermatology, and stem cells as a DFG-Fellow (Wuerzburg, Germany; 2007-2009). Then, he was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, he was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010-2012). He authored and co-authored more than 100 publications (including peer-reviewed ISI research and review articles, books, book chapters, conference proceedings, patents). He is often invited as a speaker; keynote/featured speaker and (co-) chairman to reputed world congresses and institutions, where he is offering speeches in various areas of medicine, sciences, and technology
His research interest mainly focuses in related to preventive, personalized, translational, and integrative, nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy.
Veterinary and Animal Medicine
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: firstname.lastname@example.org
Copyright © 2020 Boffin Access Limited.